Despite spending more than $1 billion every year on drugs, insecticide-treated nets, diagnostics, and public health campaigns, malaria remains deeply entrenched in Nigeria, a paradox experts at the Nigerian Institute of Medical Research (NIMR) attribute not to failed science but to biological resistance, environmental conditions, human behaviour, and weak implementation gaps.
Prof. Muhammad Ali Pate, Nigeria’s coordinating minister of Health and Social Welfare, , has estimated the economic burden of malaria at between $1.1 billion and $1.6 billion annually in healthcare costs and lost productivity, warning that the figure could rise to $2.8 billion by 2030.
Pate noted that the disease drains household incomes through high out-of-pocket spending while slowing national growth by reducing workforce productivity and discouraging tourism and investment.